Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

Completed · Phase 4

Conditions studied: Asthma, COPD

In brief

An analysis of the costs and outcomes associated with hospitalization and treatment of Levalbuterol versus Racemic Albuterol in subjects with Asthma and COPD.

Key facts

Study ID

NCT00667797

Run by

Sumitomo Pharma America, Inc.

People needed

486

Starts

2003-03-01

Expected to finish

2005-05-01

Last updated by the study team

2012-02-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female subjects must be at least greater than or equal to 18 years of age at the time of consent.
• Subjects must have history of asthma or COPD for at least 6 months prior to hospitalization.
• Subjects must have been hospitalized due to an exacerbation of their disease and required further treatment with a nebulized beta2-adrenergic agonist.
• Subjects must have an oxygen saturation level greater than or equal to 90% with greater than or equal to 40% face mask supplemental oxygen.

You may not qualify if…

• Subjects who are likely to be in the Intensive Care Unit (ICU) or Critical Care Unit (CCU).
• Based upon history or physical exam in the ED or Clinic, subjects with known or suspected cause of pulmonary symptoms other than asthma or COPD, such as pneumonia, pulmonary embolism, cystic fibrosis, or angioedema. Subjects with CHF that are admitted with a primary admission diagnosis of COPD are not excluded.
• Female subjects who are pregnant or breast feeding.
• Subjects who have participated in an investigational drug study within 30 days of study entry or have previously participated in the current trial.
• Subjects who are planning to receive elective surgical procedures during the 30 day period after hospital discharge.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Chula Vista, California, United States
• Study site — Oakland, California, United States
• Study site — Wheat Ridge, Colorado, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Brandon, Florida, United States
• Study site — Des Moines, Iowa, United States
• Study site — Johnson City, New Jersey, United States
• Study site — Great Neck, New York, United States
• Study site — Syracuse, New York, United States
• Study site — Chapel Hill, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Portland, Oregon, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Houston, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.